Table 1.
Parameter | Patients | Death | MST | Univariate analysisa | Multivariate analysisb | ||
---|---|---|---|---|---|---|---|
No. | No. | (months) | HR (95% CI) | P | HR (95% CI) | P | |
Age (years) | |||||||
≤58 | 259 | 111 | 65.5 | 1.00 | 1.00 | ||
>58 | 257 | 123 | 57.6 | 1.16 (0.9–1.50) | 0.254 | 1.28 (0.97–1.69) | 0.079 |
Sex | |||||||
Male | 389 | 173 | 63.3 | 1.00 | 1.00 | ||
Female | 127 | 61 | 46.7 | 1.07 (0.80–1.43) | 0.657 | 1.08 (0.67–1.76) | 0.752 |
Smoking status | |||||||
Never | 158 | 76 | 46.5 | 1.00 | 1.00 | ||
Ever | 358 | 158 | 63.9 | 0.91 (0.69–1.20) | 0.494 | 1.05 (0.65–1.69) | 0.842 |
Alcohol intake | |||||||
Never | 311 | 139 | 61.6 | 1.00 | 1.00 | ||
Ever | 205 | 95 | 57.7 | 0.98 (0.75–1.27) | 0.871 | 0.99 (0.72–1.36) | 0.946 |
Family history of cancer | |||||||
No | 440 | 202 | 59.1 | 1.00 | 1.00 | ||
Yes | 76 | 32 | NA | 0.89 (0.61–1.29) | 0.538 | 0.86 (0.58–1.27) | 0.451 |
Histological types | |||||||
Squamous Carcinoma | 242 | 106 | 67.7 | 1.00 | 1.00 | ||
Adenocarcinoma | 249 | 124 | 46.5 | 1.22 (0.94–1.58) | 0.137 | 1.37 (0.99–1.89) | 0.055 |
Others | 25 | 4 | NA | 0.29 (0.11–0.79) | 0.015 | 0.26 (0.06–1.09) | 0.065 |
TNM stage | |||||||
Ia | 38 | 5 | NA | 1.00 | 1.00 | ||
Ib | 87 | 23 | NA | 2.34 (0.89–6.16) | 0.085 | 2.63 (0.99–6.99) | 0.053 |
IIa | 62 | 24 | NA | 3.78 (1.44–9.92) | 0.007 | 4.2 (1.59–11.13) | 0.004 |
IIb | 63 | 26 | NA | 4.70 (1.80–12.24) | 0.002 | 5.24 (1.98–13.87) | 0.001 |
IIIa | 168 | 102 | 23.3 | 8.35 (3.40–20.53) | <.0001 | 8.68 (3.47–21.69) | <.0001 |
IIIb | 28 | 21 | 16 | 12.64 (4.75–33.64) | <.0001 | 11.13 (4.07–30.48) | <.0001 |
IV | 39 | 26 | 17 | 10.74 (4.12–28.05) | <.0001 | 10.21 (3.86–27.03) | <.0001 |
Missing | 31 | ||||||
Laterality | |||||||
Left | 236 | 117 | 41.9 | 1.00 | 1.00 | ||
Right | 275 | 113 | 66.3 | 0.79 (0.61–1.03) | 0.077 | 0.93 (0.71–1.22) | 0.589 |
Others | 5 | ||||||
Surgical approach | |||||||
Lobectomy or sublobectomy | 442 | 181 | 85.3 | 1.00 | 1.00 | ||
Pneumonectomy | 74 | 53 | 18.6 | 2.56 (1.88–3.49) | <.0001 | 1.82 (1.28–2.58) | 0.001 |
Chemotherapyc | |||||||
No | 209 | 87 | NA | 1.00 | 1.00 | ||
Yes | 307 | 147 | 48.9 | 1.07 (0.82–1.40) | 0.613 | 0.87 (0.64–1.20) | 0.398 |
Radiotherapyc | |||||||
No | 372 | 156 | 84.8 | 1.00 | 1.00 | ||
Yes | 144 | 78 | 38.7 | 1.24 (0.95–1.63) | 0.120 | 1.04 (0.75–1.44) | 0.812 |
DNA source | |||||||
Fresh | 126 | 33 | NA | 1.00 | 1.00 | ||
FFPE | 390 | 201 | 57.6 | 1.34 (0.92–1.95) | 0.132 | 1.42 (0.97–2.09) | 0.073 |
FFPE, formalin‐fixed paraffin‐embedded; MST, median survival time; OS, overall survival; HR, hazards ratio; 95% confidence interval, 95% CI; not available, NA.
univariate analysis.
Adjusted by other variables in Table 1.
Chemotherapy or Radiotherapy after operation.